Insider Buying: GTx CEO Acquires 10,000 Shares of Stock (GTXI)
GTx (NASDAQ:GTXI) CEO Marc Steven Hanover bought 10,000 shares of the stock on the open market in a transaction that occurred on Tuesday, August 19th. The shares were purchased at an average cost of $1.01 per share, with a total value of $10,100.00. Following the completion of the purchase, the chief executive officer now directly owns 178,138 shares of the company’s stock, valued at approximately $179,919. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of GTx (NASDAQ:GTXI) traded up 0.04% during mid-day trading on Thursday, hitting $0.9814. The stock had a trading volume of 2,533 shares. GTx has a 52-week low of $0.81 and a 52-week high of $2.36. The stock has a 50-day moving average of $1.20 and a 200-day moving average of $1.45. The company’s market cap is $74.6 million.
GTx (NASDAQ:GTXI) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.15) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.12) by $0.03. During the same quarter last year, the company posted ($0.20) earnings per share. On average, analysts predict that GTx will post $-0.48 earnings per share for the current fiscal year.
GTx, Inc is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (NASDAQ:GTXI) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss).
Receive News & Ratings for GTx Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GTx Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.